Trial Profile
Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Jun 2023
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Hypotension; Orthostatic hypotension
- Focus Therapeutic Use
- 23 Jun 2023 Status changed from recruiting to completed.
- 10 Feb 2020 Planned primary completion date changed from 1 Dec 2019 to 1 Dec 2020.
- 01 Aug 2018 New trial record